Boston Scientific Corporation announced that it has signed a definitive agreement to acquire Xlumena, Inc., a venture-backed medical device company...
Pancreas transplantation treats insulin-dependent diabetes with or without concurrent end-stage renal disease. Pancreas transplantation increases survival versus no transplant, increases survival when performed as...
Aerie Pharmaceuticals announced that the FDA has approved Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% to reduce elevated intraocular pressure...
The EU has given CE Mark approval to market the Axios Stent and Delivery System, from Xlumena, for biliary tract...
Beconase Allergy / Hayfever is indicated for the prevention and treatment of allergic rhinitis, including hayfever, in adults aged 18 and over. Beconase Allergy/Hayfever provides symptomatic relief from nasal congestion, runny nose, sneezing, itchy nose, eye symptoms (such as itching, watering, redness) and associated sinus discomfort.
After a long period of little change, glaucoma surgery has experienced a dramatic rise in the number of possible procedures in the last two decades. Glaucoma filtering surgeries with mitomycin C and glaucoma drainage devices remain the standard of surgical care.
Beconase Aqueous Nasal Spray is indicated for the prophylaxis and treatment of perennial and seasonal allergic rhinitis including hayfever, and vasomotor rhinitis. Beclometasone dipropionate has a potent anti-inflammatory effect within the respiratory tract, with a lower incidence and severity of adverse events than those observed when corticosteroids are administered systemically.
1. The dissolution of cholesterol stones in patients: • with one or more X-ray radiolucent (X-ray negative) gallstones, preferably with a diameter of not more than 2 cm, in a well-functioning gall bladder; • refusing a surgical procedure or in which surgical intervention is not indicated; • with whom an oversaturation of cholesterol has been shown by chemical analysis of the bile produced by duodenum drainage. 2. Primary Biliary Cholangitis. Paediatric population 3. Hepatobiliary disorder associated with cystic fibrosis in children aged 6 years to 18 years.